Oraverse Injection (2018-04-20)

OraVerse Injection Recall Summary OraVerse Injection has been recalled across Canada due to product safety concerns. This is a Class I recall, which indicates a serious safety issue. The recall affects OraVerse Injection products distributed throughout Canada.

Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2018-04-27
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/89f06f98-f67a-4d77-a1bf-d906a9d1cb53